Genetic testing industry news
Funding rounds, product launches, research findings, and policy updates — published 3× per week.
IndustryGRAIL's Galleri Multi-Cancer Early Detection Test Advances Toward Broader Medicare Coverage
GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.
2026-06-23
ResearchCertain Lung Cancer Biomarkers Slip Through DNA-Only Testing, Study Warns
New findings show DNA-based tests may miss key lung cancer biomarkers, raising questions about the adequacy of single-modality genomic profiling.
2026-08-06
ProductDatar Cancer Genetics Wins FDA Clearance for Dual DNA+RNA Comprehensive Genomic Profiling Assay
Datar Cancer Genetics receives FDA clearance for CellDx-Tissue, a comprehensive genomic profiling assay for solid tumors using both DNA and RNA.
2026-08-05
ResearchPrecision Medicine Needs More Precise Diagnostics to Fulfill Its Clinical Promise
Experts argue that advances in precision medicine are being bottlenecked by diagnostics that can't yet match therapeutic specificity.
2026-08-04
IndustrySingle-Cell Multiomics Market Projected to Reach $18.20 Billion by 2035 as Technology Matures
The single-cell multiomics market is forecast to hit $18.20B by 2035, signaling accelerating adoption across clinical and research genomics.
2026-08-03
FundingDavid Sinclair Startup Raises $80M to Bring Anti-Aging Gene Therapy into Clinical Trials
A startup co-founded by longevity researcher David Sinclair has raised $80M to fund a clinical trial of an anti-aging gene therapy.
2026-08-02
ResearchLarge Genomic Atlas Maps How Pregnancy Reshapes Maternal Biology at the Molecular Level
A large-scale genomic atlas reveals how pregnancy fundamentally alters maternal biology, with major implications for precision medicine and prenatal care.
2026-08-01
IndustryGene Solutions Eyes Hong Kong IPO as Southeast Asian Genomics Market Heats Up
Vietnam's Gene Solutions is pursuing a Hong Kong IPO to finance regional expansion, signaling growing investor appetite for Asian genomics.
2026-07-31
ResearchSingapore's National Precision Medicine Program Demonstrates How Genomic Data Translates into Real Clinical Practice
Singapore's National Precision Medicine program publishes findings on translating large-scale genomic data into actionable healthcare practice.
2026-07-30
IndustryGermany's Precision Medicine Pilot Moves from Blueprint to Reality with Data Infrastructure Now in Place
Germany's national precision medicine pilot has cleared its foundational data infrastructure hurdle, signaling a new phase of clinical genomics at scale.
2026-07-29
ProductRegeneron's FDA-Approved Neurosensory Gene Therapy Marks a Turning Point for Genetic Medicine
Regeneron has won FDA approval for the first neurosensory gene therapy, expanding the clinical frontier of genetic medicine into hearing and sensory disorders.
2026-07-28
ResearchEthical Challenges in Genome Sequencing and Precision Medicine Demand Industry-Wide Reckoning
Genomics leaders are confronting mounting ethical questions around genome sequencing and precision medicine as clinical adoption accelerates globally.
2026-07-27
ResearchBlended Genome–Exome Sequencing Cuts Costs Without Sacrificing Diagnostic Quality
A blended genome–exome sequencing approach delivers equivalent diagnostic accuracy at meaningfully lower cost, new research shows.
2026-07-26
IndustryHillsborough County Closes Three Cold Cases with Advanced DNA Technology
Three decades-old cold cases in Hillsborough County have been solved using modern DNA technology, underscoring forensic genomics' growing investigative power.
2026-07-25
IndustrySuspect Identified in 31-Year-Old Cold Case Murder Using DNA Technology: A Testament to Forensic Genomics
DNA technology has identified a suspect in the 31-year-old murder of a young mother, underscoring forensic genomics' growing power to resolve cold cases.
2026-07-24
ProductGuardant Health's Expanded Liquid Biopsy Panel Redraws the Boundaries of Advanced Cancer Testing
FDA approves new Guardant360 Liquid CDx with a 100x expanded genomic footprint, setting a new benchmark for liquid biopsy panels.
2026-07-23
ResearchGraduate Student's Precision Medicine Research Targets Genomic Equity Gap in Underserved Communities
A St. Mary's University graduate student is leveraging medical genomics to broaden access to precision medicine in underrepresented populations.
2026-07-22
IndustryInstruments of Self-Knowledge: What Your Genome Can — and Can't — Tell You About Yourself
Direct-to-consumer genetic testing turned DNA from an abstract concept into something a person can read for themselves. What that means depends entirely on how the reading is offered.
2026-07-21
ResearchVietnam Accelerates Next-Generation DNA Testing to Identify Fallen Soldiers from Past Conflicts
Vietnam is deploying next-generation DNA sequencing technology to identify the remains of soldiers lost in historical conflicts.
2026-07-21
PolicyMichigan Legislation Spotlights DNA Evidence as a Cornerstone of Wrongful Conviction Reform
New Michigan bills aim to lower barriers to overturning wrongful convictions, with DNA testing emerging as a central evidentiary mechanism.
2026-07-20
PolicySilicon Valley's Push to Genetically Engineer Babies Forces a Reckoning for the Genomics Industry
Tech investors are funding efforts to produce genetically engineered babies despite global bans, raising urgent questions for clinical genomics.
2026-07-19
ResearchDNA Technology Opens New Pathways for Foster Youth Seeking Biological Family Connections
DNA testing tools are being applied to help foster youth locate biological relatives, expanding the humanitarian reach of consumer genomics platforms.
2026-07-18
ResearchPrecision Psychiatry Challenges Genomics as the Primary Lens for Mental Health Treatment
Neuroscientist Amit Etkin argues brain activity biomarkers, not genomics, will define the future of precision psychiatry.
2026-07-17
FundingAccurEdit Raises $75M to Advance Gene Editing Therapies Showing Early Clinical Promise
China-based AccurEdit has secured $75M to develop gene editing therapies demonstrating encouraging early-stage results.
2026-07-16
FundingGene Solutions Eyes Hong Kong IPO to Fuel Southeast Asian Genomics Expansion
Vietnam's Gene Solutions is pursuing a Hong Kong IPO to finance its regional expansion across Southeast Asia's fast-growing genomics market.
2026-07-15
ProductRegeneron Wins FDA Approval for First Neurosensory Gene Therapy, Marking a Genomic Medicine Milestone
Regeneron has received FDA approval for the first neurosensory gene therapy, a landmark moment for genomic medicine and rare disease treatment.
2026-07-14
IndustryAI in Genomics Market Poised to Reach $9.32 Billion by 2030 as Precision Medicine Accelerates Adoption
The AI in genomics market is projected to hit $9.32 billion by 2030, driven by surging demand for precision medicine applications worldwide.
2026-07-13
ResearchBlended Genome–Exome Sequencing Cuts Costs Without Sacrificing Data Quality
A blended genome–exome sequencing approach delivers cost savings over standard methods while maintaining diagnostic-grade data quality.
2026-07-12
ResearchNIH's All of Us Program Becomes World's Largest Integrated Genomics and Health Database
The All of Us Research Program has surpassed all rivals to claim the title of the world's largest integrated genomics and health database.
2026-07-11
ProductNeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
NeoGenomics debuts an FDA-approved PTEN IHC companion diagnostic, expanding precision oncology options for prostate cancer patients.
2026-07-10
ProductGuardant Health's Guardant360 Liquid CDx Earns FDA Approval with 100x Expanded Panel Footprint
FDA approves the new Guardant360 Liquid CDx as the largest FDA-approved liquid biopsy panel, dramatically expanding its genomic coverage.
2026-07-08
IndustryDNA Diagnostics Market Projected to Hit $24.7 Billion by 2034 as Precision Medicine Drives Global Demand
The global DNA diagnostics market is forecast to reach $24.7B by 2034, fueled by precision medicine adoption and rapid genomic advancements.
2026-07-07
Sponsored content
Reach genetic testing decision-makers with your story
Sponsored articles appear in the News feed and the weekly newsletter. $500/article.